4
Changes in Ownership
Tarsus Pharmaceuticals, Inc. Filed Acc 0001788542-23-000006
Chief Commercial Officer sold 2,400 shares at $20.05 ($48,120)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Mottiwala Aziz · Chief Commercial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-07-19 | Sale : show line 1 in the form 10b5-1 | −2,400 | $20.05 | $48,120 | 45,806 | D |
| Open-market sales · 2,400 sh · avg $20.05 · $48,120 | ||||||
Loading xslF345X05/wk-form4_1689976000.xml…